[Comment] U-ACTIVATE long-term efficacy and safety outcomes for upadacitinib in ulcerative colitis
Upadacitinib is a targeted, synthetic, oral, small molecule with preferential inhibition for JAK1 receptors. It is now one of a ...
Tag: ulcerative
[Articles] Long-term efficacy and safety of upadacitinib in patients with moderately to severely active ulcerative colitis: an interim analysis of the phase 3 U-ACTIVATE long-term extension study
This interim analysis supports the positive long-term risk–benefit profile for upadacitinib 15 mg and 30 mg among patients with moderately ...
:max_bytes(150000):strip_icc()/Health-GettyImages-1765430464-c23b82d74c6e45a180154e60d65a0b67.jpg?w=350&resize=350,250&ssl=1 "Ulcerative Colitis Rash Signs and Symptoms")
Ulcerative Colitis Rash Signs and Symptoms
Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the innermost lining of the colon ...
Cancer risk linked to p53 in ulcerative colitis: Study
Berlin , October 25 (ANI): Researchers in Michael Sigal's lab at the Max Delbruck Center and Charite - Universitatsmedizin Berlin ...
